• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911420300
Device Problems Occlusion Within Device (1423); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Congestive Heart Failure (1783); Death (1802); Dyspnea (1816); Thrombosis (2100)
Event Date 01/01/2016
Event Type  Death  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Promus element plus clinical study it was reported that the patient died.In (b)(6) 2012, the patient presented due to stable angina and was referred for cardiac catheterization.Subsequently, the index procedure was performed.Target lesion #1 was a de novo lesion located in the mid right coronary artery (rca) with 80% stenosis and was 20mm long with a reference vessel diameter of 3.0mm.Target lesion #1 was treated with pre-dilatation and placement of a 3.00mmx28mm promus element plus drug-eluting stent, with 0% residual stenosis.Target lesion #2 was a de novo lesion located in the proximal rca with 70% stenosis and was 16mm long with a reference vessel diameter of 3.0mm.Target lesion #2 was treated with direct stent placement using a 3.00mmx20mm promus element plus drug-eluting stent, with 0% residual stenosis.On the next day, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2016, the patient presented per emergency medical services (ems) due to out of hospital cardiac arrest.In the morning, the patient's symptoms became worse and she pressed her life alert button.The patient was intubated, intravenous (iv) access was obtained and was placed on chest compression and epinephrine.After second dose of epinephrine, the patient had return of spontaneous circulation.After electrocardiogram (ekg) and chest x-ray, the patient again lost pulses and cardiopulmonary resuscitation (cpr) was resumed.The patient again had return of spontaneous circulation after repeat epinephrine dose.Subsequently, hypothermic protocol was initiated and improvement of vitals was noted.The patient was also placed on iv lasix for congestive heart failure (chf) exacerbation.Four days later, after discussion with the patient's family about the poor prognosis, it was decided to withdraw life support systems and subsequent comfort care measures were initiated.Subsequently, the patient expired.The primary cause of death is cardiac arrest.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that stent thrombosis occurred as per adjudication results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5410235
MDR Text Key37464074
Report Number2134265-2016-00341
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/08/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/05/2012
Device Model NumberH7493911420300
Device Catalogue Number39114-2030
Device Lot Number14885306
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/14/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/20/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age74 YR
-
-